Fredun Pharmaceuticals Limited Q1 FY27 earnings call summary

Earnings call of 13 Aug 2026, summarised by AI from the filing.

Target ₹800 cr this year; management expects to cross it.

Key takeaways

1. FY27 revenue Target ₹800 cr this year; management expects to cross it.
2. Q1 boost Higher growth from additional orders booked at old prices in last quarter.
3. Margin risk May sacrifice margins to increase penetration and product acceptance.

Original filing on BSE

Fredun Pharmaceuticals Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (13 Aug 2026)
• Q4 FY26: Earnings call (10 Jun 2026)
• Q3 FY26: Earnings call (12 Feb 2026)
• Q2 FY26: Earnings call (11 Nov 2025)
• Q1 FY26: Earnings call (1 Aug 2025)
• Other events: Call transcript (6 Jun 2026), Strategy deck (10 Jun 2025), Strategy deck (10 Jun 2025)